paroxetine has been researched along with Psychoses, Drug in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, S; Ito, T; Kaneko, Y; Kashiwa, A; Nishikawa, T; Umino, A | 1 |
Christensen, RC | 1 |
Bastani, AJ; Bastani, JB; Troester, MM | 1 |
Bartel, RL; Goodhue, A; Smith, NB | 1 |
4 other study(ies) available for paroxetine and Psychoses, Drug
Article | Year |
---|---|
Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Fluoxetine; Head Movements; Locomotion; Methamphetamine; Mice; Paroxetine; Psychoses, Substance-Induced; Secondary Prevention; Selective Serotonin Reuptake Inhibitors | 2007 |
Adverse interaction of paroxetine and cyproheptadine.
Topics: Cyproheptadine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Paroxetine; Psychoses, Substance-Induced | 1995 |
Serotonin syndrome and fluvoxamine: a case study.
Topics: Adult; Antidepressive Agents, Second-Generation; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors; Syndrome; Time Factors | 1996 |
Exacerbation of psychosis by phenylpropanolamine.
Topics: Adult; Female; Hallucinations; Humans; Methamphetamine; Nasal Decongestants; Paranoid Disorders; Paroxetine; Perphenazine; Phenylpropanolamine; Psychoses, Substance-Induced; Recurrence; Substance-Related Disorders | 2000 |